Lovastatin may reduce the risk of erectile dysfunction following radiation therapy for prostate cancer

Acta Oncol. 2016 Dec;55(12):1500-1502. doi: 10.1080/0284186X.2016.1223882. Epub 2016 Sep 1.
No abstract available

MeSH terms

  • Brachytherapy / adverse effects*
  • Erectile Dysfunction / drug therapy*
  • Erectile Dysfunction / etiology
  • Follow-Up Studies
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Lovastatin / therapeutic use*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Prostatic Neoplasms / radiotherapy*
  • Risk Factors

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lovastatin